However, during early and late stage of AD, an increase in soluble Aβ levels leads to mTOR hyperactivity, which should in turn suppress autophagosome formation (i.e., reduced Aβ sequestration) (for details see Autophagosome formation in Mathematical model). The gene discussed is MTOR; the disease is Alzheimer disease.